Table 4.

Risk factor analysis for COVID -19.

Characteristics	OR	95% CI	P value
Gender (male vs. female)	3.312	1.979–5.544	0.000
Age ≥ 70 years	19.811	4.473–87.741	0.001
BMI > 25	3.717	1.966 -7.062	0.001
Severity evaluation at admission	13.206	8.550–20.397	0.000
Temperature > 39 °C	5.279	2.305–12.090	0.000
Cough	2.574	1.429–4.542	0.002
Shortness of breath	11.281	6.883–18.490	0.000
Hemoptysis	7.307	2.263–23.595	0.000
Hypertension	4.105	2.572–6.554	0.000
Diabetes	2.176	1.161–4.078	0.015
Secondary bacterial infection	9.686	5.146–18.323	0.000
Lung consolidation	4.264	2.668–6.815	0.000
Lymphocyte count (10e9/l)	0.145	0.080–0.263	0.000
Neutrophils/lymphocytes (< 3 vs. ≥ 3)	7.211	3.980–13.064	0.000
Alanine aminotransferase (≤ 40 vs. > 40 U/L)	2.710	1.639–4.482	0.000
Aspartate aminotransferase (≤ 40 vs. > 40 U/L)	5.139	3.100–8.520	0.000
Creatine kinase (≤ 185 vs. > 185 U/L)	4.114	2.312–7.319	0.000
Lactate dehydrogenase (≤ 250 vs. > 250 U/L)	8.104	4.733–13.876	0.000
C-reactive protein (≤ 10 vs. > 10 mg/L)	5.959	3.510–10.119	0.000